A bioinformatics analysis of differentially expressed proteins in plasma exosome of acute-on-chronic liver failure patients with different prognoses

Yan JIAO; Ying ZHANG; Honglin SHI; Wang LU; Dexi CHEN; Yu CHEN; Hongbo SHI

doi:10.3969/j.issn.1001-5256.2021.04.022

Volume 37 Issue 4

Apr. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(4): 834-840

PDF( 4411 KB)

A bioinformatics analysis of differentially expressed proteins in plasma exosome of acute-on-chronic liver failure patients with different prognoses

DOI: 10.3969/j.issn.1001-5256.2021.04.022

Yan JIAO^{1, 2},
Ying ZHANG^{1, 2},
Honglin SHI^{1, 2
,
,},
Wang LU³,
Dexi CHEN^{1, 2},
Yu CHEN³,
Hongbo SHI^{1, 2}

1.
Beijing Institute of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China
2.
Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Beijing 100069, China
3.
Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Fourth Department of Liver Disease, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China

Received Date: 2020-10-13
Accepted Date: 2020-11-05
Published Date: 2021-04-20

Abstract

Abstract

Objective To investigate the differentially expressed proteins in the plasma exosome of acute-on-chronic liver failure (ACLF) patients with different prognoses, to analyze their functions and biological processes, and to provide a basis for clinical diagnosis. Methods A prospective study was performed for 10 ACLF patients who were hospitalized and diagnosed in Beijing YouAn Hospital, Capital Medical University, from July 2019 to October 2019, and the patients were followed up for 90 days. The patients who died or received liver transplantation were enrolled as liver transplantation/death group (5 patients), and the patients who survived were enrolled as survival group (5 patients). The Mann-Whitney U test was used for comparison of general data between the two groups. The label-free quantitative proteomic method was used for identification and quantitative analysis of plasma exosome proteins to screen out differentially expressed proteins, and a functional enrichment analysis was performed. R-3.5.1 software was used to perform a hierarchical cluster analysis of differentially expressed proteins to analyze the biological processes involving these proteins. Results A total of 860 proteins were identified by the exosome proteomic analysis, and according to the criteria of upregulation > 1.2 folds or downregulation > 1.2 folds (P < 0.05), there were 116 differentially expressed proteins. Compared with the liver transplantation/death group, the survival group had 62 upregulated proteins and 54 downregulated proteins. The bioinformatics analysis showed that these differentially expressed proteins mainly participated in immune reaction, signal transduction, vesicle-mediated transport, cell death, and cell proliferation and were closely associated with the signaling pathways including inflammatory response, carbohydrate and amino acid metabolism, hepatocyte injury, and hepatocyte regeneration. Conclusion Differentially expressed proteins screened out by the label-free quantitative proteomic method can be used as serological markers for the early diagnosis and prognostic evaluation of ACLF.
- Acute-On-Chronic Liver Failure,
- Exosomes,
- Proteomics,
- Computational Biology

FullText(HTML)

References(33)

References

[1]	TANG CM, YAU TO, YU J. Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments[J]. World J Gastroenterol, 2014, 20(20): 6262-6278. DOI: 10.3748/wjg.v20.i20.6262.
[2]	SARIN SK, KEDARISETTY CK, ABBAS Z, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J]. Hepatol Int, 2014, 8(4): 453-471. DOI: 10.1007/s12072-014-9580-2.
[3]	SARIN SK, CHOUDHURY A. Acute-on-chronic liver failure: Terminology, mechanisms and management[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(3): 131-149. DOI: 10.1038/nrgastro.2015.219.
[4]	HIRSOVA P, IBRAHIM SH, VERMA VK, et al. Extracellular vesicles in liver pathobiology: Small particles with big impact[J]. Hepatology, 2016, 64(6): 2219-2233. DOI: 10.1002/hep.28814.
[5]	XU S, ZHANG LP. Research advances in the role of exosomes in non-neoplastic liver diseases[J]. J Clin Hepatol, 2020, 36(4): 940-943. DOI: 10.3969/j.issn.1001-5256.2020.04.052. 徐帅, 张立平. 外泌体在非肿瘤性肝脏疾病中的研究进展[J]. 临床肝胆病杂志, 2020, 36(4): 940-943. DOI: 10.3969/j.issn.1001-5256.2020.04.052.
[6]	VERMA VK, LI H, WANG R, et al. Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles[J]. J Hepatol, 2016, 64(3): 651-660. DOI: 10.1016/j.jhep.2015.11.020.
[7]	NOJIMA H, FREEMAN CM, SCHUSTER RM, et al. Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate[J]. J Hepatol, 2016, 64(1): 60-68. DOI: 10.1016/j.jhep.2015.07.030.
[8]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medicial Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[9]	JING HM, ZHANG T, YANG F, et al. Manganese-related differential proteomic studies of cerebrospinal fluid from rats by label free method[J]. J Toxicol, 2012, 26(4): 247-253. https://www.cnki.com.cn/Article/CJFDTOTAL-WSDL201204001.htm 敬海明, 张拓, 杨帆, 等. Label free方法研究大鼠脑脊液中锰毒性相关的差异蛋白质组[J]. 毒理学杂志, 2012, 26(4): 247-253. https://www.cnki.com.cn/Article/CJFDTOTAL-WSDL201204001.htm
[10]	DEMORY BECKLER M, HIGGINBOTHAM JN, FRANKLIN JL, et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS[J]. Mol Cell Proteomics, 2013, 12(2): 343-355. DOI: 10.1074/mcp.M112.022806.
[11]	JI H, GREENING DW, BARNES TW, et al. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components[J]. Proteomics, 2013, 13(10-11): 1672-1686. DOI: 10.1002/pmic.201200562.
[12]	ALBILLOS A, LARIO M, ÁLVAREZ-MON M. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance[J]. J Hepatol, 2014, 61(6): 1385-1396. DOI: 10.1016/j.jhep.2014.08.010.
[13]	GUO YY, YUAN CB, YU HY, et al. Difference of T lymphocyte subsets in peripheral blood of children with chronic hepatitis B and liver failure[J]. Chin Hepatol, 2014, 19(7): 515-517. https://www.cnki.com.cn/Article/CJFDTOTAL-ZUAN201407011.htm 郭银燕, 袁春蓓, 俞海英, 等. 慢性乙型肝炎与肝衰竭患儿外周血T淋巴细胞亚群的差异[J]. 肝脏, 2014, 19(7): 515-517. https://www.cnki.com.cn/Article/CJFDTOTAL-ZUAN201407011.htm
[14]	VEIGA-PARGA T, SEHRAWAT S, ROUSE BT. Role of regulatory T cells during virus infection[J]. Immunol Rev, 2013, 255(1): 182-196. DOI: 10.1111/imr.12085.
[15]	SMIRNOVA E, GRIPARIC L, SHURLAND DL, et al. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells[J]. Mol Biol Cell, 2001, 12(8): 2245-2256. DOI: 10.1091/mbc.12.8.2245.
[16]	YANG X, WANG H, NI HM, et al. Inhibition of Drp1 protects against senecionine-induced mitochondria-mediated apoptosis in primary hepatocytes and in mice[J]. Redox Biol, 2017, 12: 264-273. DOI: 10.1016/j.redox.2017.02.020.
[17]	XU S, PI H, CHEN Y, et al. Cadmium induced Drp1-dependent mitochondrial fragmentation by disturbing calcium homeostasis in its hepatotoxicity[J]. Cell Death Dis, 2013, 4: e540. DOI: 10.1038/cddis.2013.7.
[18]	PALMA E, MA X, RIVA A, et al. Dynamin-1-like protein inhibition drives megamitochondria formation as an adaptive response in alcohol-induced hepatotoxicity[J]. Am J Pathol, 2019, 189(3): 580-589. DOI: 10.1016/j.ajpath.2018.11.008.
[19]	GALLOWAY CA, LEE H, BROOKES PS, et al. Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease[J]. Am J Physiol Gastrointest Liver Physiol, 2014, 307(6): G632-641. DOI: 10.1152/ajpgi.00182.2014.
[20]	YU T, WANG L, LEE H, et al. Decreasing mitochondrial fission prevents cholestatic liver injury[J]. J Biol Chem, 2014, 289(49): 34074-34088. DOI: 10.1074/jbc.M114.588616.
[21]	STRITT S, NURDEN P, TURRO E, et al. A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss[J]. Blood, 2016, 127(23): 2903-2914. DOI: 10.1182/blood-2015-10-675629.
[22]	LYNCH ED, LEE MK, MORROW JE, et al. Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous[J]. Science, 1997, 278(5341): 1315-1318. DOI: 10.1126/science.278.5341.1315
[23]	YANG J, ZHOU L, ZHANG Y, et al. DIAPH1 Is Upregulated and inhibits cell apoptosis through ATR/p53/Caspase-3 signaling pathway in laryngeal squamous cell carcinoma[J]. Dis Markers, 2019, 2019: 6716472. DOI: 10.1155/2019/6716472.
[24]	LIU D, FU X, WANG Y, et al. Protein diaphanous homolog 1 (Diaph1) promotes myofibroblastic activation of hepatic stellate cells by regulating Rab5a activity and TGFβ receptor endocytosis[J]. FASEB J, 2020, 34(6): 7345-7359. DOI: 10.1096/fj.201903033R.
[25]	SUN Z, FENG D, FANG B, et al. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor[J]. Mol Cell, 2013, 52(6): 769-782. DOI: 10.1016/j.molcel.2013.10.022.
[26]	BURRAGE LC, MADAN S, LI X, et al. Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency[J]. JCI Insight, 2020, 5(4). DOI: 10.1172/jci.insight.132342.
[27]	UCHIHARA T, MIYAKE K, YONEMURA A, et al. Extracellular vesicles from cancer-associated fibroblasts containing annexin A6 induces FAK-YAP activation by stabilizing β1 integrin, enhancing drug resistance[J]. Cancer Res, 2020, 80(16): 3222-3235. DOI: 10.1158/0008-5472.CAN-19-3803.
[28]	ALVAREZ-GUAITA A, BLANCO-MUÑOZ P, MENESES-SALAS E, et al. Annexin A6 is critical to maintain glucose homeostasis and survival during liver regeneration in mice[J]. Hepatology, 2020, 72(6): 2149-2164. DOI: 10.1002/hep.31232.
[29]	TORTI SV, TORTI FM. Iron and cancer: More ore to be mined[J]. Nat Rev Cancer, 2013, 13(5): 342-355. DOI: 10.1038/nrc3495.
[30]	ALKHATEEB AA, CONNOR JR. The significance of ferritin in cancer: Anti-oxidation, inflammation and tumorigenesis[J]. Biochim Biophys Acta, 2013, 1836(2): 245-254. DOI: 10.1016/j.bbcan.2013.07.002.
[31]	LUNOVA M, GOEHRING C, KUSCUOGLU D, et al. Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload[J]. J Hepatol, 2014, 61(3): 633-641. DOI: 10.1016/j.jhep.2014.04.034.
[32]	WANG AR, LI XL, MEN QS, et al. Serum ferritin and liver disease[J/CD]. Chin J Liver Dis(Electronic Edition), 2020, 12(4): 34-37. DOI: 10.3969/j.issn.1674-7380.2020.04.006. 王傲然, 李晓玲, 门秋爽, 等. 血清铁蛋白与肝脏疾病研究进展[J/CD]. 中国肝脏病杂志(电子版), 2020, 12(4): 34-37. DOI: 10.3969/j.issn.1674-7380.2020.04.006.
[33]	DENG JH, CHEN ZP, HUANG MM, et al. Clinical significance of Ferritin Light Chain and its expression in serum of patients with chronic hepatopathy[J]. Modern Prevent Med, 2016, 43(18): 3444-3447. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201618046.htm 邓敬桓, 陈智平, 黄美梦, 等. FTL在慢性肝病患者血清中的表达及临床意义[J]. 现代预防医学, 2016, 43(18): 3444-3447. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201618046.htm

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(3) / Tables(4)

Get Citation

PDF

XML

Article Metrics

Article views (712) PDF downloads(55)

A bioinformatics analysis of differentially expressed proteins in plasma exosome of acute-on-chronic liver failure patients with different prognoses

DOI: 10.3969/j.issn.1001-5256.2021.04.022

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

A bioinformatics analysis of differentially expressed proteins in plasma exosome of acute-on-chronic liver failure patients with different prognoses

DOI: 10.3969/j.issn.1001-5256.2021.04.022

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content